About: Clinical trials in the pandemic age: What is fit for purpose?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical trials in the pandemic age: What is fit for purpose? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical trials in the pandemic age: What is fit for purpose?
Creator	Mundel, Trevor Heaton, Penny Cammack, Nick Dolley, Shawn Hartman, Dan Hudson, Ian Netsi, Elena Norman, Thea
Source	Medline; PMC
abstract	It is critical to ensure that COVID-19 studies provide clear and timely answers to the scientific questions that will guide us to scalable solutions for all global regions. Significant challenges in operationalizing trials include public policies for managing the pandemic, public health and clinical capacity, travel and migration, and availability of tests and infrastructure. These factors lead to spikes and troughs in patient count by location, disrupting the ability to predict when or if a trial will reach recruitment goals. The focus must also be on understanding how to provide equitable access to these interventions ensuring that interventions reach those who need them the most, be it patients in low resource settings or vulnerable groups. We introduce a website to be used by The Bill & Melinda Gates Foundation, Wellcome Trust, and other funders of the COVID Therapeutics Accelerator that accept proposals for future clinical research. The portal enables evaluations of clinical study applications that focus on study qualities most likely to lead to informative outcomes and completed studies.
has issue date	2020-06-09(xsd:dateTime)
bibo:doi	10.12688/gatesopenres.13146.1
bibo:pmid	32656501
has license	cc-by
sha1sum (hex)	3fe380d04795e214bbb37cabdfe649d647030ff7
schema:url	https://doi.org/10.12688/gatesopenres.13146.1
resource representing a document's title	Clinical trials in the pandemic age: What is fit for purpose?
has PubMed Central identifier	PMC7324688
has PubMed identifier	32656501
schema:publication	Gates Open Res
resource representing a document's body	covid:3fe380d04795e214bbb37cabdfe649d647030ff7#body_text
is schema:about of	named entity 'studies' named entity 'scientific' named entity 'access' named entity 'troughs' named entity 'pandemic' named entity 'RESULTS' named entity 'PATIENT' named entity 'PORTAL' named entity 'NEED' named entity 'OUTCOMES' named entity 'study' named entity 'managing' named entity 'COVID-19' named entity 'These' named entity 'recruitment' named entity 'lead' named entity 'informative' named entity 'availability' named entity 'regions' named entity 'PubMed' named entity 'age' named entity 'equitable access' named entity 'Global health' named entity 'scalable' named entity 'peer review' named entity 'quality assessments' named entity 'New York City' named entity 'clinical trials' named entity 'systematic review' named entity 'open access' named entity 'quality monitoring' named entity 'observational data' named entity 'public policies' named entity 'vaccine' named entity 'article processing charge' named entity 'COVID-19' named entity 'COVID-19' named entity 'healthy living' named entity 'clinical trial' named entity 'clinical trials' named entity 'go/no-go' named entity 'coronavirus' named entity 'research methods' named entity 'sustainability' named entity 'hydroxychloroquine' named entity 'vaccines' named entity 'decision making' named entity 'azithromycin' named entity 'clinical trial' named entity 'phase 1' named entity 'high-quality' named entity 'biostatistics' named entity 'epidemiological studies' named entity 'clinical trials' named entity 'lower-income countries' named entity 'predictive model' named entity 'COVID' named entity 'high-income countries' named entity 'clinical research' named entity 'clinical trial' named entity 'COVID-19' named entity 'observational studies' named entity 'COVID-19 pandemic' named entity 'LMIC' named entity 'scientific questions' named entity 'COVID' named entity 'COVID' named entity 'scientific questions' named entity 'evidence-based' named entity 'COVID-19 pandemic' named entity 'bit.ly' named entity 'peer review' named entity 'paradigm' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software